D-0107-2027 Class II Ongoing
FDA drug recall D-0107-2027 was initiated by Direct Rx on Sep 29, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 493 jars.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Sep 29, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 493 jars
Product description
Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States
Code information
LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0107-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026